Pharmacological Treatment of Alzheimer's Disease: Scientific and Clinical Aspects
Editat de Gustavo Alves Andrade dos Santosen Limba Engleză Paperback – 30 mar 2023
Alzheimer’s disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years.
This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer’s disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers.
Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 653.27 lei 38-45 zile | |
Springer International Publishing – 30 mar 2023 | 653.27 lei 38-45 zile | |
Hardback (1) | 1082.49 lei 3-5 săpt. | |
Springer International Publishing – 29 mar 2022 | 1082.49 lei 3-5 săpt. |
Preț: 653.27 lei
Preț vechi: 687.65 lei
-5% Nou
Puncte Express: 980
Preț estimativ în valută:
125.08€ • 130.25$ • 103.78£
125.08€ • 130.25$ • 103.78£
Carte tipărită la comandă
Livrare economică 10-17 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030943851
ISBN-10: 3030943852
Pagini: 231
Ilustrații: XIV, 231 p. 11 illus., 5 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.47 kg
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030943852
Pagini: 231
Ilustrații: XIV, 231 p. 11 illus., 5 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.47 kg
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
1. Introduction.- 2. Principles of Pharmacology in Dementia.- 3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer's Disease.- 4. The Use of Esterase Inhibitors.- 5. Pharmacology of NMDA (N-methyl-D-aspartate) receptor antagonists in Alzheimer’s Disease.- 6. Supportive Pharmacological Treatment.- 7. Herbal Medicines and Supplements.- 8. Emergency Situations.- 9. Relationships between Treatment and Clinical Evaluations.- 10. New Perspectives for Treatment in Alzheimer's Disease.
Notă biografică
Gustavo Alves Andrade dos Santos is Pharmacist-Biochemist, holds a PhD in Biotechnology, Master's degree in Pharmacy and a Post Doctorate in Anatomy and Surgery from the University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil. He also studied Neurobiology at the University of Chicago, Clinical Pharmacy at University Central of Florida, USA; Hospital Pharmacy, Necker Hospital in Paris, France, and completed a post-graduation in Hospital Pharmacy, Oswaldo Cruz Faculty, São Paulo, Brazil.
Dr. Santos is currently a Professor at the Faculty of Medicine São Leopoldo Mandic, Araras, São Paulo, Brazil and Oswaldo Cruz Faculty, São Paulo, Brazil; coordinator of the technical group of pharmaceutical care to the elderly of the Regional Pharmacy Council of the State of São Paulo. He is member of the International Society of the Alzheimer's Association to promote research and treatment of Alzheimer's disease (ISTAART) and member of the American Society of Health System Pharmacists (ASHP).
Textul de pe ultima copertă
Alzheimer’s disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years.
This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer’s disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers.
Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.
Caracteristici
Provides pharmacological basis applied to clinical practice for the Alzheimer's disease treatment Offers insights on new treatment perspectives Gathers contribution from specialists with solid professional experience